Management of Elevated Lipids in Diabetic Patients

Initial Pharmacologic Therapy

The American Diabetes Association recommends starting a moderate-intensity statin immediately as first-line therapy, combined with intensive lifestyle modifications, for diabetic patients aged 40-75 years, regardless of age, with a goal of reducing LDL cholesterol by 30-50% from baseline 1
For diabetic patients with additional ASCVD risk factors, the American College of Cardiology recommends escalating to high-intensity statin therapy, targeting LDL cholesterol reduction ≥50% from baseline and an LDL goal <70 mg/dL 1

The American Heart Association recommends adopting a Mediterranean or DASH eating pattern with saturated fat <7% of total daily calories and complete elimination of trans fats, and increasing viscous fiber intake through oats, legumes, and citrus fruits 1, 2
The American Diabetes Association recommends adding plant stanols/sterols (2 grams daily) and omega-3 fatty acids from fish or supplements to the diet 1, 2

The American College of Cardiology recommends obtaining a baseline lipid panel before initiating statin therapy, then rechecking at 4-12 weeks post-initiation to assess response and medication adherence, and monitoring lipids annually after achieving target levels 1, 3, 4

The American Diabetes Association recommends intensifying lifestyle therapy and optimizing glycemic control first for patients with triglycerides ≥150 mg/dL or low HDL, even if HbA1c is already 5% 1, 3
The American College of Cardiology recommends adding ezetimibe as second-line therapy, or considering PCSK9 inhibitor if multiple ASCVD risk factors are present, for patients with LDL remaining ≥70 mg/dL on maximum statin 1, 3

The American Heart Association recommends not delaying statin initiation waiting for lifestyle modifications to "work first", and not assuming excellent glycemic control eliminates cardiovascular risk 1
The American College of Cardiology recommends continuing statin therapy at maximum tolerated dose for patients >75 years already on statins, and initiating moderate-intensity therapy after discussing benefits and risks for patients >75 years not on statins 1, 3